Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FX2EF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $39,559
Award facts
- Contract value 100% obligated
- $39,559.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $39,559.44 for the supply of Entyvio 300 mg vials. The contract, issued on September 5, 2025, with an ultimate completion date of September 26, 2025, carries firm fixed-price terms and represents a delivery order with no set-aside designation. The award was made by the Defense Logistics Agency (DLA), the Department of Defense's combat support agency responsible for supplying military medical facilities worldwide.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting the medical supply needs of military health facilities globally. As a consistent performer in federal pharmaceutical procurement, DMS Pharmaceutical Group has established itself as a critical supplier within the Department of Defense's pharmaceutical supply chain through its specialized distribution capabilities.
Quick answers
Who was awarded contract SPE2DB25FX2EF?
SPE2DB25FX2EF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FX2EF worth?
The government has obligated $39,559 on SPE2DB25FX2EF.
Is contract SPE2DB25FX2EF an order under another contract?
Yes. SPE2DB25FX2EF is a delivery order under SPE2DB22D9353, an indefinite delivery contract.
Was contract SPE2DB25FX2EF competed?
The extent of competition for SPE2DB25FX2EF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award